🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Epidemiologic multicenter prospective study in advanced NSCLC patients with...
Status
Completed
Location
Centre Hospitalier D Argenteuil
Start Date
2016-07-21
Trial ID
NCT02785562
Treatments Being Tested
Gastric cancer is one of the cancers with a high mortality rate globally, a...
Status
Recruiting
Location
Changzhi People's Hospital
Start Date
2025-01-01
Trial ID
NCT07069842
Multi-center observational clinical study to evaluate the application value...
Status
Unknown
Location
Parc de Salut Mar - Hospital del Mar
Start Date
2021-02-01
Trial ID
NCT05641870
GENCONCOR-2 is a translational research aimed to compare the molecular prof...
Status
Recruiting
Location
Blokhin's Russian Cancer Research Center
Start Date
2026-04-01
Trial ID
NCT07464470
Treatments Being Tested
The purpose of this study is to assess the prevalence of pre-treatment tumo...
Status
Completed
Location
Research Site
Start Date
2019-01-17
Trial ID
NCT03788746
Multi-cohort exploratory prospective study. Participation in the ALCINA 4 s...
Status
Recruiting
Location
Institut Curie
Start Date
2022-05-19
Trial ID
NCT05088395
Treatments Being Tested
The phenotype of circulating tumor cells (CTCs) is supposed to be significa...
Status
Recruiting
Location
Hunan Cancer Hospital
Start Date
2019-03-01
Trial ID
NCT05326295
Treatments Being Tested
To evaluate the safety, dosimetry and efficacy of 99mTc/68Ga labeled anti-P...
Status
Completed
Location
Shanghai General Hospital
Start Date
2018-02-15
Trial ID
NCT02978196
Treatments Being Tested
This is a prospective, open-label, multi-cohort, non-randomized, multicente...
Status
Recruiting
Location
Banner Health MD Anderson
Start Date
2021-05-07
Trial ID
NCT04614103
Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibito...
Status
Unknown
Location
CHU d'ANGERS
Start Date
2019-04-09
Trial ID
NCT03865511
Treatments Being Tested